SEC Filing Form 4: Richard Stephen Acquires 10,402 Shares of Anika Therapeutics, Inc. Common Stock

Richard Stephen, a director at Anika Therapeutics, Inc., acquired 10,402 shares of common stock on June 18, 2026. This acquisition was made at no cost, as indicated by the transaction price of $0.00. Following this transaction, Mr. Stephen now owns 58,273 shares of the company's common stock. The acquired shares represent restricted stock units (RSUs) that vest in full on the earlier of the 2027 annual meeting of stockholders or June 18, 2027. The filing is a Form 4, indicating a change in beneficial ownership.